Sustained Benefit of Cytarabine Conditioning in MCL Patients Undergoing Transplant

Five-year follow-up data from the phase III MCL Younger trial found a sustained benefit associated with high-dose cytarabine conditioning prior to autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma (MCL) who received induction therapy with chemoimmunotherapy. These findings were presented at the 2021 American Society of Hematology Annual Meeting. Initial Findings from … Continue reading Sustained Benefit of Cytarabine Conditioning in MCL Patients Undergoing Transplant